Impact of HIV infection and HAART on serum lipids in men
- PMID: 12799406
- DOI: 10.1001/jama.289.22.2978
Impact of HIV infection and HAART on serum lipids in men
Abstract
Context: Alterations in serum lipid values have been widely reported among persons infected with human immunodeficiency virus (HIV) type 1 treated with highly active antiretroviral therapy (HAART), but no data have yet been reported on changes from preseroconversion lipid values.
Objective: To describe changes in serum cholesterol levels associated with HIV infection and antiretroviral medication exposure, and 1-time assessment of triglyceride levels post-HAART initiation.
Design, setting, and participants: The Multicenter AIDS Cohort Study, a prospective study in which homosexual and bisexual men were enrolled and from which 50 of 517 HIV seroconverters were drawn for the analysis herein, who later initiated HAART, involving measurements of stored serum samples obtained between 1984 and 2002.
Main outcome measures: Changes in levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) at 6 time points during an average of 12 years; 1-time assessment of triglyceride levels from the third post-HAART clinic visit.
Results: Among the 50 men, notable declines in mean serum TC (-30 mg/dL [-0.78 mmol/L]), HDL-C (-12 mg/dL [-0.31 mmol/L]), and LDL-C values (-22 mg/dL [-0.57 mmol/L]) were observed after HIV infection. Following HAART initiation, there were large increases in mean TC and LDL-C values (50 and 21 mg/dL [1.30 and 0.54 mmol/L], respectively); however, the mean changes from the preseroconversion values were 20 mg/dL (0.52 mmol/L) (95% confidence interval [CI], -1 to 41) and -1 mg/dL (-0.03 mmol/L) (95% CI, -25 to 22), respectively. Mean HDL-C remained below baseline levels throughout follow-up. The median value (interquartile range) of triglycerides was 225 mg/dL (2.54 mmol/L) (147-331 mg/dL).
Conclusions: Before treatment, HIV infection results in substantial decreases in serum TC, HDL-C, and LDL-C levels. Subsequent HAART initiation is associated with increases in TC and LDL-C but little change in HDL-C. Increases in TC and LDL-C observed after about 3 years of HAART possibly represent a return to preinfection serum lipid levels after accounting for expected age-related changes.
Similar articles
-
Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.HIV Med. 2007 Jul;8(5):280-7. doi: 10.1111/j.1468-1293.2007.00470.x. HIV Med. 2007. PMID: 17561873
-
Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):304-11. doi: 10.1097/qai.0b013e31815e7453. J Acquir Immune Defic Syndr. 2008. PMID: 18398971
-
Effects of highly active antiretroviral therapy on paediatric metabolite levels.HIV Med. 2006 Jan;7(1):16-24. doi: 10.1111/j.1468-1293.2005.00337.x. HIV Med. 2006. PMID: 16313288
-
Meta-analysis indicates that resistant starch lowers serum total cholesterol and low-density cholesterol.Nutr Res. 2018 Jun;54:1-11. doi: 10.1016/j.nutres.2018.02.008. Epub 2018 Mar 5. Nutr Res. 2018. PMID: 29914662
-
Effectiveness of ezetimibe in human immunodeficiency virus patients treated for hyperlipidaemia: a systematic review and meta-analysis.Infect Dis (Lond). 2022 Feb;54(2):99-109. doi: 10.1080/23744235.2021.1982140. Epub 2021 Sep 30. Infect Dis (Lond). 2022. PMID: 34590982
Cited by
-
Inflammation-induced foam cell formation in chronic inflammatory disease.Immunol Cell Biol. 2015 Sep;93(8):683-93. doi: 10.1038/icb.2015.26. Epub 2015 Mar 10. Immunol Cell Biol. 2015. PMID: 25753272 Review.
-
Dyslipidaemia in HIV-1-infected patients receiving protease inhibitors after initial treatment with first-line-based non-nucleoside reverse transcriptase inhibitors: a cross-sectional study.BMJ Open. 2012 Aug 8;2(4):e001317. doi: 10.1136/bmjopen-2012-001317. Print 2012. BMJ Open. 2012. PMID: 22874631 Free PMC article.
-
HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction.J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):209-16. doi: 10.1097/QAI.0000000000000419. J Acquir Immune Defic Syndr. 2015. PMID: 25588033 Free PMC article.
-
Biomarkers and HIV-associated cardiovascular disease.Curr Opin HIV AIDS. 2010 Nov;5(6):511-6. doi: 10.1097/COH.0b013e32833ed7ec. Curr Opin HIV AIDS. 2010. PMID: 20978394 Free PMC article. Review.
-
Platelet Transcriptome Profiling in HIV and ATP-Binding Cassette Subfamily C Member 4 (ABCC4) as a Mediator of Platelet Activity.JACC Basic Transl Sci. 2018 Mar 1;3(1):9-22. doi: 10.1016/j.jacbts.2017.10.005. eCollection 2018 Feb. JACC Basic Transl Sci. 2018. PMID: 30062189 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical